In March 2011, Boston Scientific released their first EUS‐FNA needle. There are currently two Boston Scientific needles on the market. With successes in the aspirate needle aspect of the market, Boston Scientific would like to introduce a core needle. To this end, the Olin SCOPE team has been asked to address three aspects of the project: identify important needle parameters, determine appropriate tissue substitute, and assess Boston Scientific EUS-FNA needles.